FES Center is Recognized as the Most Valuable Non-Profit in the Field of Neuromodulation Research

FES Center is Recognized as the Most Valuable Non-Profit in the Field of Neuromodulation Research

Cleveland, OH – October 24, 2014

The Cleveland Functional Electrical Stimulation (FES) Center is recognized as the Most Valuable Non-Profit in the field of Neuromodulation Research. Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced the winners of the 2014 Gold Electrode Awards at the 2014 Neurotech Leaders Forum on October 20 in San Francisco. Awards were presented in five categories: Best New Product, Most Promising Start-Up, Most Valuable Financial Professional, Most Valuable Non-Profit, and Neurotechnology Researcher of the Year.

The Gold Electrode Award for Most Valuable Non-Profit was presented to the Cleveland FES Center. According to James Cavuoto, editor and publisher of Neurotech Business Report, the Cleveland FES Center was selected for their long history of cutting-edge research in neuroprosthetics, neurorehabilitation, and implanted devices.

“The Center has also been at the forefront of translational research, helping guide the transition from research to regulatory approval,” Mr. Cavuoto said. “The Center has been an active advocate for neurotechnology research, performing education and public awareness campaigns on behalf of novel therapies for neurological disorders such as spinal cord injury.”

Robert F. Kirsch, PhD, executive director of the FES Center and a professor and chairman of the Department of Biomedical Engineering at Case Western Reserve University, said: “We are extremely honored to accept this award on behalf of our many research participants and investigative teams and institutional partners. It is the dedication of those participating in the research coupled with the teams effort and drive that continue the successes and advancements in this field. ”

The Cleveland FES Center is the leader in the meaningful restoration of movement and function through neuromodulation and neurostimulation research and applications developed for clinical deployment.